Antitrust

As antitrust enforcement surges worldwide, Charles River Associates' strategic re-hire of M&A specialist Hitesh Makhija signals a new front in the talent wars.

The York Water Company announces a stock offering to fund major investments. We analyze the impact on investors, customers, and the utility's future.

A proposed $108.5M FDA funding boost aims to modernize infant formula rules, paving the way for plant-based options and a more secure supply chain.

O2Gold terminates a major Quebec acquisition and its associated financing, casting uncertainty on its future and highlighting the risks in junior mining.

From the nation's capital to pristine wilderness, a new report warns that unchecked development and pollution are pushing America's vital rivers to the brink.

With its lead depression drug nearing Phase 3, AtaiBeckley faces investors to tackle the regulatory and commercial hurdles of psychedelic medicine.

FDA approves the first generic of a vital nutrition drug, granting Apotex a 180-day exclusive edge and signaling major cost savings for healthcare.

AriseAlpha's new app promises easy crypto returns, replacing costly mining rigs. But can automated bots truly outsmart the market's notorious volatility?

A Canadian drone maker gains top military approval in Ukraine, leveraging its unique 'ITAR-flexible' status to meet surging global defense demand.

The AI and data analytics firm's new cybersecurity certification positions it as a key partner for sensitive defense missions in a shifting compliance landscape.

A new IP firm, led by an industry veteran, acquired 500+ Avaya networking patents. The move signals a new era for tech licensing and innovation.

As DSCR loans boom, a new toolkit from HomeLife Mortgage aims to give investors the speed and clarity needed to navigate a complex financing market.

A new report reveals that where you live dictates your medical costs, with prices, not the care you use, driving a more than twofold spending gap.

A new report argues companies have the tools but lack the strategy, making organizational misalignment the top cybersecurity threat heading into 2026.

Optro's inaugural EMEA conference signals a major push into Europe's complex GRC market, focusing on AI governance and transforming risk into opportunity.

Facing a shareholder revolt after a damning indictment, Supermicro launches a major probe into a $2.5B shadow trade scheme. Is it too little, too late?

Brazil launches Fair Play, an AI prosecutor to identify online racism. It promises access to justice but faces scrutiny over ethics and accuracy.

As Democrats demand Trump’s removal, Ralph Nader and Bruce Fein gather top legal minds to define the constitutional grounds for impeachment.

FOX News is integrating Kalshi's real-time prediction market data, a move that could revolutionize news but sparks debate over accuracy and ethics.

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.